← Back to patent-cliff list
Liposomal Cetirizine
Tier C — Watch / tradeLiposomal Cetirizine
Nicox
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：HRH1
Indications (approved)：输尿管结石, Allergic rhinitis
Regional status
US
-
EU
No progress
2007-09-01
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Liposomal Cetirizine?
Approved indications include: 输尿管结石, Allergic rhinitis.
When does the Liposomal Cetirizine patent expire?
No public expiry year is available for Liposomal Cetirizine yet; this page updates once verified.
How do I get a quote for Liposomal Cetirizine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06